AFF1 and precursor B-cell acute lymphoblastic leukemia: To estimate the antiproliferative efficacy of VEN in B-ALL cells, we first incubated cell lines with KMT2A::AFF1 translocation (SEM, RS4;11) and KMT2A wild-type cell lines REH, NALM-6 with increasing concentrations of VEN.